Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
60,235
-
Share change
-
-26,067
-
Total reported value
-
$55,849
-
Price per share
-
$0.94
-
Number of holders
-
7
-
Value change
-
-$59,101
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Bone Biologics Corp - COM NEW (BBLG) as of Q4 2024
As of 31 Dec 2024,
Bone Biologics Corp - COM NEW (BBLG) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,235 shares.
The largest 7 holders included
UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, CITIGROUP INC, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and SBI Securities Co., Ltd..
This page lists
7
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.